| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Colonoscopy | 47 | 2020 | 738 | 8.94 | Why? |
| Colonic Polyps | 20 | 2019 | 117 | 6.21 | Why? |
| Colorectal Neoplasms | 35 | 2020 | 1884 | 4.99 | Why? |
| Adenoma | 15 | 2019 | 215 | 3.82 | Why? |
| Endoscopic Mucosal Resection | 10 | 2019 | 63 | 2.45 | Why? |
| Early Detection of Cancer | 14 | 2020 | 1956 | 2.19 | Why? |
| Colonography, Computed Tomographic | 6 | 2018 | 58 | 1.96 | Why? |
| Cathartics | 6 | 2019 | 41 | 1.55 | Why? |
| Methylene Blue | 2 | 2019 | 175 | 1.26 | Why? |
| Intestinal Mucosa | 7 | 2019 | 1046 | 1.22 | Why? |
| Endoscopy, Gastrointestinal | 13 | 2020 | 1545 | 1.13 | Why? |
| Narrow Band Imaging | 3 | 2018 | 24 | 1.13 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 4 | 2018 | 237 | 0.98 | Why? |
| Image Enhancement | 3 | 2019 | 177 | 0.93 | Why? |
| Neoplasms, Second Primary | 2 | 2018 | 100 | 0.88 | Why? |
| Capsule Endoscopy | 7 | 2018 | 75 | 0.85 | Why? |
| Mass Screening | 9 | 2020 | 8005 | 0.85 | Why? |
| Colon | 9 | 2019 | 669 | 0.83 | Why? |
| Rectum | 4 | 2019 | 495 | 0.82 | Why? |
| Injections | 3 | 2018 | 237 | 0.82 | Why? |
| Colonoscopes | 1 | 2019 | 9 | 0.80 | Why? |
| Gastroesophageal Reflux | 2 | 2018 | 124 | 0.79 | Why? |
| Gastric Mucosa | 2 | 2017 | 141 | 0.77 | Why? |
| Esophageal Neoplasms | 3 | 2019 | 357 | 0.75 | Why? |
| Myotomy | 1 | 2017 | 12 | 0.73 | Why? |
| Polyps | 1 | 2018 | 31 | 0.73 | Why? |
| Dreams | 1 | 2019 | 90 | 0.70 | Why? |
| Cholangiography | 1 | 2017 | 19 | 0.70 | Why? |
| Esophageal Achalasia | 1 | 2017 | 30 | 0.69 | Why? |
| Bile Duct Neoplasms | 2 | 2018 | 172 | 0.69 | Why? |
| Coloring Agents | 1 | 2018 | 116 | 0.68 | Why? |
| Stomach | 2 | 2017 | 141 | 0.66 | Why? |
| Endoscopy | 4 | 2020 | 1564 | 0.66 | Why? |
| Gastroscopy | 4 | 2018 | 112 | 0.65 | Why? |
| Costs and Cost Analysis | 2 | 2018 | 694 | 0.64 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.61 | Why? |
| Cholangitis, Sclerosing | 1 | 2017 | 106 | 0.60 | Why? |
| Diagnostic Errors | 2 | 2019 | 865 | 0.59 | Why? |
| Histones | 1 | 2018 | 371 | 0.59 | Why? |
| Colectomy | 1 | 2018 | 327 | 0.58 | Why? |
| Propofol | 1 | 2017 | 172 | 0.58 | Why? |
| Colonic Neoplasms | 5 | 2019 | 295 | 0.58 | Why? |
| Hypokalemia | 1 | 2017 | 195 | 0.58 | Why? |
| Gastrointestinal Neoplasms | 5 | 2021 | 392 | 0.58 | Why? |
| Self Expandable Metallic Stents | 4 | 2018 | 52 | 0.57 | Why? |
| Cholangiocarcinoma | 1 | 2017 | 186 | 0.55 | Why? |
| Colon, Ascending | 3 | 2018 | 16 | 0.55 | Why? |
| Incidental Findings | 1 | 2018 | 487 | 0.52 | Why? |
| Neoplasm Recurrence, Local | 3 | 2019 | 1063 | 0.50 | Why? |
| Endoscopy, Digestive System | 3 | 2020 | 352 | 0.45 | Why? |
| Pancreatic Neoplasms | 4 | 2018 | 609 | 0.39 | Why? |
| Administration, Oral | 5 | 2019 | 2340 | 0.39 | Why? |
| Patient Compliance | 2 | 2018 | 1468 | 0.38 | Why? |
| Intestinal Polyposis | 2 | 2018 | 9 | 0.37 | Why? |
| Sphincterotomy, Endoscopic | 2 | 2019 | 27 | 0.37 | Why? |
| Population Surveillance | 4 | 2019 | 4967 | 0.37 | Why? |
| Endosonography | 3 | 2018 | 150 | 0.37 | Why? |
| Precancerous Conditions | 3 | 2018 | 108 | 0.36 | Why? |
| Gastritis, Atrophic | 2 | 2018 | 20 | 0.36 | Why? |
| Colon, Transverse | 2 | 2017 | 9 | 0.35 | Why? |
| Gastrointestinal Hemorrhage | 3 | 2019 | 669 | 0.35 | Why? |
| Endoscopes | 2 | 2018 | 72 | 0.34 | Why? |
| Barrett Esophagus | 2 | 2019 | 68 | 0.34 | Why? |
| Deep Sedation | 2 | 2018 | 121 | 0.33 | Why? |
| Digestive System Neoplasms | 2 | 2018 | 146 | 0.31 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.31 | Why? |
| Conscious Sedation | 2 | 2018 | 222 | 0.30 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2017 | 75 | 0.29 | Why? |
| Clinical Competence | 2 | 2019 | 3263 | 0.29 | Why? |
| Needles | 2 | 2017 | 87 | 0.29 | Why? |
| Intestinal Diseases | 2 | 2018 | 231 | 0.29 | Why? |
| Quality Indicators, Health Care | 3 | 2018 | 580 | 0.28 | Why? |
| Artificial Intelligence | 1 | 2019 | 3543 | 0.27 | Why? |
| Adenomatous Polyps | 3 | 2018 | 21 | 0.27 | Why? |
| Dyspepsia | 2 | 2018 | 60 | 0.27 | Why? |
| Quality Improvement | 3 | 2018 | 2435 | 0.27 | Why? |
| Magnetic Resonance Imaging | 4 | 2018 | 6551 | 0.26 | Why? |
| Cecum | 3 | 2018 | 63 | 0.26 | Why? |
| Humans | 91 | 2021 | 930598 | 0.26 | Why? |
| Water | 2 | 2018 | 765 | 0.26 | Why? |
| Antifoaming Agents | 2 | 2019 | 2 | 0.26 | Why? |
| Polyethylene Glycols | 2 | 2018 | 574 | 0.25 | Why? |
| Communication | 1 | 2020 | 5206 | 0.24 | Why? |
| Pancreas | 2 | 2018 | 398 | 0.23 | Why? |
| Biopsy | 4 | 2018 | 2811 | 0.23 | Why? |
| Gallstones | 2 | 2019 | 64 | 0.23 | Why? |
| Neoplasm Invasiveness | 6 | 2019 | 582 | 0.22 | Why? |
| Pancreatic Cyst | 2 | 2017 | 11 | 0.22 | Why? |
| Occult Blood | 3 | 2018 | 275 | 0.21 | Why? |
| Air | 2 | 2018 | 145 | 0.21 | Why? |
| Equipment Contamination | 3 | 2018 | 1308 | 0.21 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 3 | 2020 | 1316 | 0.21 | Why? |
| Simethicone | 1 | 2019 | 1 | 0.21 | Why? |
| Hemostasis, Endoscopic | 1 | 2019 | 24 | 0.20 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.20 | Why? |
| Laxatives | 1 | 2019 | 18 | 0.20 | Why? |
| Operative Time | 2 | 2018 | 450 | 0.20 | Why? |
| Helicobacter pylori | 2 | 2016 | 262 | 0.19 | Why? |
| Cholestasis, Extrahepatic | 1 | 2018 | 5 | 0.19 | Why? |
| Dietary Fiber | 1 | 2019 | 73 | 0.19 | Why? |
| Picolines | 1 | 2018 | 7 | 0.19 | Why? |
| Rifamycins | 1 | 2019 | 20 | 0.19 | Why? |
| Cost Savings | 2 | 2018 | 296 | 0.19 | Why? |
| Citrates | 1 | 2018 | 37 | 0.19 | Why? |
| Immunochemistry | 1 | 2018 | 95 | 0.19 | Why? |
| Heller Myotomy | 1 | 2017 | 4 | 0.18 | Why? |
| Hypertonic Solutions | 1 | 2017 | 6 | 0.18 | Why? |
| Viscosupplements | 1 | 2017 | 17 | 0.18 | Why? |
| Adenocarcinoma | 2 | 2018 | 651 | 0.18 | Why? |
| Fundoplication | 1 | 2017 | 12 | 0.18 | Why? |
| Cryosurgery | 1 | 2019 | 57 | 0.18 | Why? |
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 11 | 0.18 | Why? |
| Fractals | 1 | 2018 | 25 | 0.18 | Why? |
| Esophageal pH Monitoring | 1 | 2017 | 33 | 0.18 | Why? |
| Duodenoscopes | 1 | 2017 | 16 | 0.18 | Why? |
| Esophagitis | 1 | 2017 | 21 | 0.18 | Why? |
| Intubation | 2 | 2018 | 437 | 0.18 | Why? |
| Anastomosis, Surgical | 1 | 2018 | 169 | 0.18 | Why? |
| Sigmoidoscopy | 1 | 2017 | 50 | 0.18 | Why? |
| Transcriptional Activation | 1 | 2019 | 196 | 0.18 | Why? |
| Bile Ducts | 1 | 2018 | 84 | 0.18 | Why? |
| Health Services Misuse | 1 | 2018 | 81 | 0.17 | Why? |
| Intestinal Polyps | 1 | 2017 | 11 | 0.17 | Why? |
| Citric Acid | 1 | 2018 | 116 | 0.17 | Why? |
| Rupture | 1 | 2017 | 40 | 0.17 | Why? |
| Dilatation | 1 | 2019 | 181 | 0.17 | Why? |
| Hydroxyethyl Starch Derivatives | 1 | 2017 | 22 | 0.17 | Why? |
| Anemia, Pernicious | 1 | 2016 | 8 | 0.17 | Why? |
| Cholangitis | 1 | 2018 | 81 | 0.17 | Why? |
| Europe | 6 | 2019 | 12702 | 0.17 | Why? |
| Predictive Value of Tests | 8 | 2018 | 9537 | 0.17 | Why? |
| Colonic Diseases | 1 | 2018 | 96 | 0.16 | Why? |
| Carbon Dioxide | 3 | 2018 | 917 | 0.16 | Why? |
| Carcinoma in Situ | 1 | 2017 | 58 | 0.16 | Why? |
| Glycerol | 1 | 2017 | 52 | 0.16 | Why? |
| Solutions | 1 | 2017 | 121 | 0.16 | Why? |
| Neuroendocrine Tumors | 2 | 2018 | 241 | 0.16 | Why? |
| Patient Participation | 3 | 2018 | 829 | 0.16 | Why? |
| Cholestasis | 1 | 2018 | 114 | 0.16 | Why? |
| Drug Resistance, Multiple | 1 | 2017 | 156 | 0.16 | Why? |
| Brachytherapy | 1 | 2017 | 93 | 0.16 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.15 | Why? |
| Organometallic Compounds | 1 | 2018 | 206 | 0.15 | Why? |
| Image-Guided Biopsy | 1 | 2017 | 185 | 0.15 | Why? |
| Elasticity Imaging Techniques | 1 | 2018 | 194 | 0.15 | Why? |
| Intestinal Perforation | 1 | 2018 | 178 | 0.15 | Why? |
| Hemoglobins | 2 | 2018 | 958 | 0.15 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.15 | Why? |
| Efficiency | 1 | 2018 | 420 | 0.14 | Why? |
| Drainage | 1 | 2018 | 414 | 0.14 | Why? |
| Patient Education as Topic | 3 | 2019 | 1476 | 0.14 | Why? |
| Stomach Neoplasms | 2 | 2018 | 477 | 0.14 | Why? |
| Disinfection | 2 | 2018 | 2912 | 0.14 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.14 | Why? |
| Middle Aged | 26 | 2019 | 270681 | 0.14 | Why? |
| Male | 32 | 2020 | 367725 | 0.14 | Why? |
| Gastroenterologists | 1 | 2018 | 259 | 0.14 | Why? |
| Internationality | 4 | 2020 | 3297 | 0.14 | Why? |
| Female | 32 | 2020 | 380317 | 0.13 | Why? |
| Immunohistochemistry | 2 | 2018 | 2275 | 0.13 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.13 | Why? |
| Insufflation | 3 | 2018 | 61 | 0.13 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.13 | Why? |
| Neoplasms | 2 | 2020 | 17251 | 0.13 | Why? |
| Time Factors | 9 | 2020 | 31397 | 0.13 | Why? |
| Patient Care Planning | 1 | 2018 | 582 | 0.13 | Why? |
| Pancreatitis | 2 | 2018 | 688 | 0.12 | Why? |
| Feces | 4 | 2018 | 4235 | 0.12 | Why? |
| Digestive System Surgical Procedures | 1 | 2019 | 677 | 0.12 | Why? |
| Risk Management | 1 | 2020 | 1044 | 0.12 | Why? |
| Biological Therapy | 1 | 2017 | 456 | 0.12 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.12 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 4 | 2020 | 9706 | 0.11 | Why? |
| Double-Blind Method | 3 | 2019 | 5988 | 0.11 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.11 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.11 | Why? |
| Swine | 2 | 2017 | 3352 | 0.11 | Why? |
| Intestine, Small | 3 | 2018 | 336 | 0.11 | Why? |
| Lymphadenopathy | 1 | 2017 | 444 | 0.11 | Why? |
| Deglutition Disorders | 1 | 2017 | 481 | 0.11 | Why? |
| Aged | 20 | 2019 | 215776 | 0.11 | Why? |
| Safety | 1 | 2018 | 1583 | 0.10 | Why? |
| False Negative Reactions | 1 | 2017 | 1785 | 0.10 | Why? |
| Gastroenterology | 2 | 2021 | 1352 | 0.10 | Why? |
| Equipment Reuse | 1 | 2017 | 985 | 0.10 | Why? |
| Italy | 12 | 2020 | 38444 | 0.10 | Why? |
| Common Bile Duct | 2 | 2019 | 21 | 0.10 | Why? |
| Anti-Inflammatory Agents | 2 | 2019 | 6153 | 0.10 | Why? |
| Patient Safety | 3 | 2020 | 4885 | 0.10 | Why? |
| Crohn Disease | 1 | 2018 | 959 | 0.10 | Why? |
| Sensitivity and Specificity | 5 | 2019 | 22971 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.09 | Why? |
| Pain, Procedural | 2 | 2018 | 51 | 0.09 | Why? |
| Metaplasia | 2 | 2018 | 43 | 0.09 | Why? |
| Guideline Adherence | 2 | 2018 | 2309 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.09 | Why? |
| Decontamination | 1 | 2017 | 1196 | 0.09 | Why? |
| Anti-Ulcer Agents | 1 | 2007 | 24 | 0.09 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.08 | Why? |
| Infection Control | 4 | 2020 | 23131 | 0.08 | Why? |
| Neoplasm Staging | 3 | 2019 | 1999 | 0.08 | Why? |
| Patient Selection | 5 | 2020 | 4560 | 0.08 | Why? |
| Occupational Health | 2 | 2020 | 3965 | 0.08 | Why? |
| Peptic Ulcer | 1 | 2007 | 85 | 0.08 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.08 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.08 | Why? |
| Catheterization | 2 | 2019 | 264 | 0.08 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.07 | Why? |
| Patient Care Management | 1 | 2017 | 1514 | 0.07 | Why? |
| Device Removal | 2 | 2018 | 221 | 0.07 | Why? |
| Observer Variation | 2 | 2018 | 622 | 0.07 | Why? |
| Palliative Care | 2 | 2018 | 2665 | 0.07 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Antibiotic Prophylaxis | 2 | 2018 | 399 | 0.07 | Why? |
| Documentation | 2 | 2018 | 332 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Delphi Technique | 2 | 2020 | 1257 | 0.07 | Why? |
| United States | 4 | 2020 | 46150 | 0.07 | Why? |
| Abdomen | 2 | 2018 | 424 | 0.07 | Why? |
| Helicobacter Infections | 1 | 2007 | 216 | 0.07 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2010 | 665 | 0.07 | Why? |
| Consensus | 4 | 2020 | 6345 | 0.06 | Why? |
| Prospective Studies | 9 | 2018 | 43301 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Treatment Outcome | 6 | 2019 | 51732 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Psoriasis | 1 | 2017 | 1739 | 0.06 | Why? |
| Risk Factors | 5 | 2018 | 71621 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Aged, 80 and over | 8 | 2018 | 88759 | 0.06 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.05 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.05 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.05 | Why? |
| Follow-Up Studies | 4 | 2020 | 17020 | 0.05 | Why? |
| HT29 Cells | 1 | 2019 | 108 | 0.05 | Why? |
| Immersion | 1 | 2018 | 18 | 0.05 | Why? |
| Double-Balloon Enteroscopy | 1 | 2018 | 2 | 0.05 | Why? |
| Diagnostic Techniques, Digestive System | 1 | 2018 | 29 | 0.05 | Why? |
| Single-Balloon Enteroscopy | 1 | 2018 | 5 | 0.05 | Why? |
| Cytochrome P-450 CYP3A | 1 | 2019 | 88 | 0.05 | Why? |
| Esophagoscopy | 1 | 2019 | 95 | 0.05 | Why? |
| Library Collection Development | 1 | 2017 | 3 | 0.05 | Why? |
| Drinking | 1 | 2018 | 69 | 0.05 | Why? |
| Patient Comfort | 1 | 2018 | 74 | 0.04 | Why? |
| Fluoroscopy | 1 | 2018 | 140 | 0.04 | Why? |
| Classification | 1 | 2017 | 55 | 0.04 | Why? |
| Validation Studies as Topic | 1 | 2017 | 121 | 0.04 | Why? |
| Histology | 1 | 2017 | 13 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2019 | 391 | 0.04 | Why? |
| Biopsy, Needle | 1 | 2018 | 303 | 0.04 | Why? |
| Risk Assessment | 5 | 2020 | 25439 | 0.04 | Why? |
| Duodenum | 1 | 2018 | 179 | 0.04 | Why? |
| Surveys and Questionnaires | 3 | 2020 | 43792 | 0.04 | Why? |
| Tumor Burden | 1 | 2019 | 369 | 0.04 | Why? |
| Hyperplasia | 1 | 2017 | 204 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| No-Show Patients | 1 | 2017 | 94 | 0.04 | Why? |
| Drug Administration Schedule | 2 | 2018 | 2324 | 0.04 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2018 | 238 | 0.04 | Why? |
| Neoplasm, Residual | 1 | 2017 | 147 | 0.04 | Why? |
| Mediastinum | 1 | 2017 | 122 | 0.04 | Why? |
| Prosthesis Failure | 1 | 2018 | 195 | 0.04 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.04 | Why? |
| Adult | 10 | 2018 | 244371 | 0.04 | Why? |
| Network Meta-Analysis | 1 | 2018 | 426 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Sterilization | 1 | 2018 | 294 | 0.04 | Why? |
| Suction | 1 | 2017 | 297 | 0.04 | Why? |
| Dissection | 1 | 2017 | 164 | 0.04 | Why? |
| Prosthesis Implantation | 1 | 2018 | 261 | 0.04 | Why? |
| Drug Substitution | 1 | 2018 | 385 | 0.04 | Why? |
| Medical History Taking | 1 | 2017 | 350 | 0.04 | Why? |
| Eating | 1 | 2018 | 395 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2019 | 1236 | 0.04 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.04 | Why? |
| Pathology | 1 | 2017 | 121 | 0.04 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.04 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.03 | Why? |
| Models, Animal | 1 | 2017 | 788 | 0.03 | Why? |
| Patient Satisfaction | 2 | 2017 | 2517 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2019 | 704 | 0.03 | Why? |
| Postoperative Complications | 3 | 2017 | 5861 | 0.03 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.03 | Why? |
| Pancreatitis, Chronic | 1 | 2013 | 37 | 0.03 | Why? |
| Anesthesia, General | 1 | 2018 | 470 | 0.03 | Why? |
| Methotrexate | 1 | 2017 | 471 | 0.03 | Why? |
| Privacy | 1 | 2018 | 636 | 0.03 | Why? |
| Checklist | 1 | 2018 | 714 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.03 | Why? |
| North America | 1 | 2017 | 1400 | 0.03 | Why? |
| Ascorbic Acid | 1 | 2018 | 676 | 0.03 | Why? |
| Withholding Treatment | 1 | 2018 | 798 | 0.03 | Why? |
| Bias | 1 | 2018 | 1109 | 0.03 | Why? |
| C-Reactive Protein | 2 | 2018 | 7972 | 0.03 | Why? |
| Video Recording | 1 | 2017 | 786 | 0.03 | Why? |
| Informed Consent | 1 | 2018 | 890 | 0.03 | Why? |
| Patient Preference | 1 | 2018 | 750 | 0.03 | Why? |
| Stents | 1 | 2018 | 916 | 0.03 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.03 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.03 | Why? |
| Animals | 2 | 2017 | 78931 | 0.03 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.03 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.03 | Why? |
| Health Facilities | 1 | 2018 | 1230 | 0.03 | Why? |
| Sarcoma | 1 | 2013 | 290 | 0.02 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.02 | Why? |
| Asia | 1 | 2017 | 2399 | 0.02 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.02 | Why? |
| Kidney Neoplasms | 1 | 2018 | 832 | 0.02 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.02 | Why? |
| Appointments and Schedules | 1 | 2017 | 1204 | 0.02 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.02 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.02 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.02 | Why? |
| Lymphoma | 1 | 2013 | 522 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.02 | Why? |
| Carcinoma, Renal Cell | 1 | 2013 | 545 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Liver Diseases | 1 | 2021 | 2698 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Thromboembolism | 1 | 2018 | 2101 | 0.02 | Why? |
| Anti-Bacterial Agents | 1 | 2007 | 10083 | 0.02 | Why? |
| Leadership | 1 | 2018 | 2241 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Inflammatory Bowel Diseases | 1 | 2021 | 3209 | 0.02 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.02 | Why? |
| Feasibility Studies | 1 | 2013 | 3467 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.01 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.01 | Why? |
| Equipment Design | 1 | 2013 | 3095 | 0.01 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.01 | Why? |
| Elective Surgical Procedures | 1 | 2018 | 5338 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.01 | Why? |
| Drug Resistance, Bacterial | 1 | 2007 | 1414 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2007 | 7268 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2016 | 93724 | 0.00 | Why? |